693.0 BC MSP code: Dermatitis due to substances taken internally – Due to drugs and medicaments

693.0 is the BC MSP diagnostic code for “Dermatitis due to substances taken internally – Due to drugs and medicaments” in BC Medical Services Plan’s September 2026 release, in effect from Sep 11, 2026.

Official description

693.0

Dermatitis due to substances taken internally – Due to drugs and medicaments

BC MSP diagnostic codes (ICD-9) · British Columbia

Notes for 693.0

BC Medical Services Plan’s list gives no includes, excludes or other notes for 693.0 or the headings above it.

Where 693.0 sits

  1. 1Valid code 693Dermatitis due to substances taken internally
  2. 2Valid code 693.0Dermatitis due to substances taken internally – Due to drugs and medicaments

Source and release

Data release
BC MSP · September 2026
Effective date
Sep 11, 2026

This page is built from the BC MSP catalog that Vero Codes reads when it suggests codes: BC Ministry of Health, Medical Services Plan’s September 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.

Frequently asked questions

What does BC MSP diagnostic code 693.0 mean?

693.0 is the BC MSP diagnostic code for “Dermatitis due to substances taken internally – Due to drugs and medicaments” in BC Medical Services Plan’s BC MSP September 2026 release.

Where is 693.0 in BC MSP?

693.0 sits under 693 Dermatitis due to substances taken internally.

What coding notes apply to 693.0?

BC Medical Services Plan’s list gives no includes, excludes or other notes for 693.0 or the headings above it.

Which BC MSP release does this page use?

It uses BC Medical Services Plan’s September 2026 release, in effect from Sep 11, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.